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MIR-141 NOT ONLY MODULATES ANOIKIS RESISTANCE OF OVARIAN CANCER 
CELLS BUT ALSO ALTERS PRE-METASTATIC NICHE FOR OVARIAN CANCER 
CELL METASTATIC COLONIZATION  
D. Chan, C.S. Mak, H.Y. Ngan  
 
The University of Hong Kong, Obs. & Gyn., Hong Kong, Hong Kong  
 
INTRODUCTION: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy 
worldwide. This disease is generally called the ‘silent killer’ because there are no symptoms and 
thus, the majority of patients are found in advanced stages accompanied by extensive metastasis. 
Most deaths from this cancer are attributed to metastatic progression. The cancer metastasis is 
determined by the priming of metastatic niche and the intrinsic properties of cancer cells to adapt 
the microenvironemntal stresses. However, the associated molecular mechanisms remain unclear.  
 
MATERIAL AND METHOD: The miRCURY™ LNA, cDNA, and proteomic array profilings in 
combination with a series of biochemical and functional analyses were performed to identify 
miR-141 as a putative miRNA in regulating anokis resistance of ovarian cancer cells through 
KLF12/survivin signaling. Both in vitro cell culture and in vivo mouse model showed miR-141 is 
an secretary miRNA, while immunofluorescent, qPCR, Proteome Profiler Human XL Cytokine 
Array Kit and functional analyses demonstrated miR-141 was able for cell-to-cell communication 
to alter host cells as a premetastatic niche.  
 
RESULTS AND DISCUSSION: Using miRCURY™ LNA Array profiling in combination with a 
series of biochemical and functional analyses, we identified Hsa-miR-141 (miR-141) was highly 
expressed in advanced serous subtype ovarian cancers. The overexpressed miR-141 could 
enhance cell survival of ovarian cancer cells against anoikis by targeting Krüppel-related zinc 
finger protein AP-2rep (KLF12). Restoration of KLF12 in miR- 141-expressing cells remarkably 
reduced, or knockdown of KLF12 similar to miR- 141 overexpression augmented, anoikis 
resistance of ovarian cancer cells through alteration of survival-associated factor, survivin. 
Luciferase reporter assay using survivin promoter luciferase plasmid (luc-survivin) indicated that 
survivin could be transcriptionally inhibited by KLF12. Intringuingly, miR-141 was found to be 
secreted from ovarian cancer cells and taken up by hFF-1 fibroblast cells. Ovarian cancer cells 
cultured in miR-141-expressing fibroblast cell medium displayed increased cell growth and cell 
migration in the presence of GROa and EMMPRIN chemokines.  
 
CONCLUSION: MiR-141 not only plays a key role in altering cancer cell plasticity against 
anoikis but also can reprogram stroma to be a pre-metastatic niche facilitating the ovarian cancer 
metastatic colonization. 
